Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-07 · accession 0001209191-22-017217 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-07 | CTKB | Yan Ming | CTO, Dir | M - OptEx | $0.3469 | +73.0K | 8.16M | +0.9% | +$25.3K |
| DM | 2022-03-08 | 2022-03-07 | CTKB | Yan Ming | CTO, Dir | M - OptEx | $0.00 | -73.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | M | A | 62,456 | $0.25 | 8,152,248 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-07 | M | A | 10,555 | $0.92 | 8,162,803 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-07 | M | D | 10,555 | $0.00 | 16,111 | D | $0.92 · — to 2030-07-24 | 10,555 Common Stock | (F1) The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 24, 2021; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-07 | M | D | 62,456 | $0.00 | 0 | D | $0.25 · 2021-06-28 to 2027-06-28 | 62,456 Common Stock |